Charles Greg Guyer

Insider Reports History

Entity
Individual
Location
C/O Biomarin Pharmaceutical Inc., 770 Lindaro St., San Rafael, California
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles Greg Guyer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BIOMARIN PHARMACEUTICAL INC EVP, Chief Technical Officer Common Stock 74,132 $6.11 M $82.44 May 3, 2024 Direct
BIOMARIN PHARMACEUTICAL INC EVP, Chief Technical Officer Stock Option (Right to Buy Common Stock) 23,630 Mar 15, 2024 Direct

Insider Reports Filed by Charles Greg Guyer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BMRN BIOMARIN PHARMACEUTICAL INC May 3, 2024 2 -349,215 4 May 7, 2024 EVP, Chief Technical Officer
BMRN BIOMARIN PHARMACEUTICAL INC Mar 15, 2024 3 -1,712,961 4 Mar 19, 2024 EVP, Chief Technical Officer
BMRN BIOMARIN PHARMACEUTICAL INC Feb 27, 2024 3 0 4 Feb 29, 2024 EVP, Chief Technical Officer
BMRN BIOMARIN PHARMACEUTICAL INC Dec 1, 2023 2 9,208 4 Dec 5, 2023 EVP, Chief Technical Officer
BMRN BIOMARIN PHARMACEUTICAL INC Aug 9, 2023 1 -500,109 4 Aug 10, 2023 EVP, Chief Technical Officer
BMRN BIOMARIN PHARMACEUTICAL INC Apr 28, 2023 2 -394,642 4 May 8, 2023 EVP, Chief Technical Officer
BMRN BIOMARIN PHARMACEUTICAL INC Mar 15, 2023 3 -162,845 4 Mar 17, 2023 EVP, Chief Technical Officer
BMRN BIOMARIN PHARMACEUTICAL INC Dec 31, 2022 1 15,727 5 Feb 10, 2023 EVP, Chief Technical Officer
BMRN BIOMARIN PHARMACEUTICAL INC Aug 8, 2022 1 -599,155 4 Aug 10, 2022 EVP, Chief Technical Officer
BMRN BIOMARIN PHARMACEUTICAL INC Apr 29, 2022 2 -317,171 4 May 6, 2022 EVP, Chief Technical Officer
BMRN BIOMARIN PHARMACEUTICAL INC Mar 15, 2022 3 -72,008 4 Mar 17, 2022 EVP, Chief Technical Officer
BMRN BIOMARIN PHARMACEUTICAL INC Dec 31, 2021 1 15,040 5 Feb 11, 2022 EVP, Chief Technical Officer